转录组
回声病毒
柯萨奇病毒
生物
免疫系统
肠道病毒
先天免疫系统
病毒学
肠道病毒71
发病机制
病毒复制
免疫学
心肌炎
病毒
免疫
细胞病变效应
干扰素
病毒病机
基因
趋化因子
病毒性心肌炎
下调和上调
微生物学
作者
Yi Xu,Xianwu Lan,Jianwei Chen,Jieyu You,Hiu Tung Ko,Chuqun Fang,Shanshan Cui,Muhammad Adnan Shereen,Zhen Luo,S. Peter Wu
标识
DOI:10.1002/adbi.202500281
摘要
Viral myocarditis (VMC) is a myocardial injury syndrome caused by enterovirus infections, including Coxsackievirus B5 (CVB5) and Echovirus 6 (ECHO6). However, the exact pathogenesis of VMC by enteroviruses remains unclear. Here, the host immune response differences in transcriptomics in human cardiomyocyte AC16 cells upon CVB5 and ECHO6 infections were explored. CVB5 and ECHO6 effectively infected AC16 cells, showing significant viral replication and cytopathic effects at 48 h post-infection. Transcriptomic analysis indicated that both CVB5 and ECHO6 infection induced a series of immune- and inflammation- related genes, including IL6, CCL3, and IFNL1, which were validated by qPCR. Additionally, Ribavirin demonstrated a certain inhibitory effect on the viral replication of both CVB5 and ECHO6 at a concentration of 50 µm. This study established a systematic comparison of the common transcriptomic differences and immune response characteristics of both CVB5 and ECHO6 infection in human cardiomyocytes. The marked upregulation of immune-related genes suggests that innate immunity and the inflammatory response play critical roles in cardiomyocytes defense against enterovirus infection. Ribavirin showed notable inhibitory activity against both CVB5 and ECHO6. The study sheds light on new insights into the foundations for the pathogenesis of enterovirus-associated VMC and the development of promising therapeutic approaches against VMC.
科研通智能强力驱动
Strongly Powered by AbleSci AI